Rommy Von Bernhardi

Prof. Dr. Rommy Von Bernhardi

Biology, Universidad de Santiago de Chile, Santiago, Región Metropolitana, Chile
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
Rommy Von BernhardiRommy Von Bernhardi
Rommy Von Bernhardi
LBLaura Eugenín-Von Bernhardi
Laura Eugenín-Von Bernhardi
JEJaime L Eugenin
Jaime L Eugenin
Aging is the main risk factor for neurodegenerative diseases. In aging, microglia undergo phenotypic changes compatible with their activation. Glial activation can lead to neuroinflammation, which is increasingly accepted as part of the pathogenesis of neurodegenerative diseases, including Alzheimer’s disease (AD). We hypothesize that in aging, aberrant microglia activation leads to a deleterious environment and neurodegeneration. In aged mice, microglia exhibit an increased expression of cytokines and an exacerbated inflammatory response to pathological changes. Whereas LPS increases nitric oxide secretion in microglia from young mice, induction of reactive oxygen species (ROS) predominates in older mice. Furthermore, there is accumulation of DNA oxidative damage in mitochondria of microglia during aging, and also an increased intracellular ROS production. Increased ROS activates the redox-sensitive nuclear factor kappa B, which promotes more neuroinflammation, and can be translated in functional deficits, such as cognitive impairment. Mitochondria-derived ROS and cathepsin B, are also necessary for the microglial cell production of interleukin-1β, a key inflammatory cytokine. Interestingly, whereas the regulatory cytokine TGFβ1 is also increased in the aged brain, neuroinflammation persists. Assessing this apparent contradiction, we have reported that TGFβ1 induction and activation of Smad3 signaling after inflammatory stimulation are reduced in adult mice. Other protective functions, such as phagocytosis, although observed in aged animals, become not inducible by inflammatory stimuli and TGFβ1. Here, we discuss data suggesting that mitochondrial and endolysosomal dysfunction could at least partially mediate age-associated microglial cell changes, and, together with the impairment of the TGFβ1-Smad3 pathway, could result in a reduction of protective activation and a facilitation of cytotoxic activation of microglia, resulting in the promotion of neurodegeneration.

2 February 2010 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
Rommy Von BernhardiRommy Von Bernhardi
Rommy Von Bernhardi
JTJuan E. Tichauer
Juan E. Tichauer
JEJaime Eugenín
Jaime Eugenín

1 May 2012 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Rommy Von BernhardiRommy Von Bernhardi
Rommy Von Bernhardi
JEJaime Eugenín
Jaime Eugenín
Alzheimer's disease (AD) is the most common cause of dementia and a progressive neurodegeneration that appears to result from multiple pathogenic mechanisms (including protein misfolding/aggregation, involved in both amyloid β-dependent senile plaques and tau-dependent neurofibrillary tangles), metabolic and mitochondrial dysfunction, excitoxicity, calcium handling impairment, glial cell dysfunction, neuroinflammation, and oxidative stress. Oxidative stress, which could be secondary to several of the other pathophysiological mechanisms, appears to be a major determinant of the pathogenesis and progression of AD. The identification of oxidized proteins common for mild cognitive impairment and AD suggests that key oxidation pathways are triggered early and are involved in the initial progression of the neurodegenerative process. Abundant data support that oxidative stress, also considered as a main factor for aging, the major risk factor for AD, can be a common key element capable of articulating the divergent nature of the proposed pathogenic factors. Pathogenic mechanisms influence each other at different levels. Evidence suggests that it will be difficult to define a single-target therapy resulting in the arrest of progression or the improvement of AD deterioration. Since oxidative stress is present from early stages of disease, it appears as one of the main targets to be included in a clinical trial. Exploring the articulation of AD pathogenic mechanisms by oxidative stress will provide clues for better understanding the pathogenesis and progression of this dementing disorder and for the development of effective therapies to treat this disease. Antioxid. Redox Signal. 16, 974–1031.

28 October 2015 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
Rommy Von BernhardiRommy Von Bernhardi
Rommy Von Bernhardi
FCFrancisca Cornejo
Francisca Cornejo
GPGuillermo E. Parada
Guillermo E. Parada
JEJaime L Eugenin
Jaime L Eugenin
Aging is the main risk factor for Alzheimer’s disease (AD); being associated with conspicuous changes on microglia activation. Aged microglia exhibit an increased expression of cytokines, exacerbated reactivity to various stimuli, oxidative stress, and reduced phagocytosis of Aβ. Whereas normal inflammation is protective, it becomes dysregulated in the presence of a persistent stimulus, or in the context of an inflammatory environment, as observed in aging. Thus, neuroinflammation can be a self-perpetuating deleterious response, becoming a source of additional injury to host cells in neurodegenerative diseases. In aged individuals, although TGFβ is upregulated, its canonical Smad3 signaling is greatly reduced and neuroinflammation persists. This age-related Smad3 impairment reduces protective activation while facilitating cytotoxic activation of microglia through several cellular mechanisms, potentiating microglia-mediated neurodegeneration. Here, we critically discuss the role of TGFβ-Smad signaling on the cytotoxic activation of microglia and its relevance in the pathogenesis of AD. Other protective functions, such as phagocytosis, although observed in aged animals, are not further induced by inflammatory stimuli and TGFβ1. Analysis in silico revealed that increased expression of receptor SR-A, involved in Aβ uptake and cell activation, by microglia exposed to TGFβ, through a Smad3-dependent mechanism could be mediated by transcriptional co-factors Smad2/3 over the MSR1 gene. We discuss that changes of TGFβ-mediated regulation could at least partially mediate age-associated microglia changes, and, together with other changes on inflammatory response, could result in the reduction of protective activation and the potentiation of cytotoxicity of microglia, resulting in the promotion of neurodegenerative diseases.

28 October 2017
Verified
Book Chapter
Closed access
PDF file
Rommy Von BernhardiRommy Von Bernhardi
Rommy Von Bernhardi
LBLaura Eugenín-Von Bernhardi
Laura Eugenín-Von Bernhardi
JEJaime L Eugenin
Jaime L Eugenin

1 August 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RARodrigo Alarcón
Rodrigo Alarcón
CFCarolina Fuenzalida
Carolina Fuenzalida
MSMarcos Santibáñez
Marcos Santibáñez
Rommy Von BernhardiRommy Von Bernhardi
Rommy Von Bernhardi
Astrocytes and microglia associate to amyloid plaques, a pathological hallmark of Alzheimer disease. Microglia are activated by and can phagocytose β-amyloid (Aβ). Scavenger receptors (SRs) are among the receptors mediating the uptake of fibrillar Aβ in vitro. However, little is known about the function of the astrocytes surrounding the plaques or the nature of their interaction with Aβ. It is unknown whether glial cells bind to nonfibrillar Aβ and if binding of astrocytes to Aβ depends on the same Scavenger receptors described for microglia. We determined the binding of glia to Aβ by an adhesion assay and evaluated the presence of scavenger receptors in glial cells by immunocytochemistry, immunohistochemistry of brain sections, and immunoblot. We found that astrocytes and microglia from neonatal rats adhered in a concentration-dependent manner to surfaces coated with fibrillar Aβ or nonfibrillar Aβ. Fucoidan and poly(I), known ligands for SR-type A, inhibited adhesion of microglia and astrocytes to Aβ and also inhibited Aβ phagocytosis. In contrast, a ligand for SR-type B like low density lipoprotein, did not compete glial adhesion to Aβ. Microglia presented immunodetectable SR-BI, SR-AI/AII, RAGE, and SR-MARCO (macrophage receptor with collagenous structure, a member of the SR-A family). Astrocytes presented SR-BI and SR-MARCO. To our knowledge, this is the first description of the presence of SR-MARCO in astrocytes. Our results indicate that both microglia and astrocytes adhere to fibrillar and nonfibrillar Aβ. Adhesion was mediated by a fucoidan-sensitive receptor. We propose that SR-MARCO could be the Scavenger receptor responsible for the adhesion of astrocytes and microglia to Aβ.